KLK3 and posterior cortical atrophy: Interestingly, a phase II clinical trial testing androgen deprivation therapy and ICB reported a reduction in PSA levels and tumor reduction in 25% of patients99 and a phase I clinical trial of the PCa vaccine sipuleucel-T combined with ICB gave promising results.